These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 3230413)

  • 1. Does the in vitro testing of the immunoreactivity of an antibody reflect its in vivo behavior?
    Van den Abbeele AD; Aaronson RA; Adelstein SJ; Kassis AI
    J Nucl Med Allied Sci; 1988; 32(4):260-7. PubMed ID: 3230413
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of immunogenicity of a BALB-c myeloma protein in BALB-c mice.
    Peaker PJ; Cicurei L; Nisonoff A
    J Immunol; 1974 Sep; 113(3):791-7. PubMed ID: 4213082
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibodies and the immunodiagnosis of plasma-cellular malignancies.
    Haaijman JJ
    Neth J Med; 1985; 28(3):102-7. PubMed ID: 3920543
    [No Abstract]   [Full Text] [Related]  

  • 4. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vivo binding behaviour of an I-123 labelled anti-granulocytes antibody (Granuloszint).
    Hasler PH; Novak-Hofer I; Bläuenstein P; Schubiger PA
    Prog Clin Biol Res; 1990; 355():299-309. PubMed ID: 2281110
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice.
    Hwang KM; Fodstad O; Oldham RK; Morgan AC
    Cancer Res; 1985 Sep; 45(9):4150-5. PubMed ID: 4028007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human monoclonal antibody developed against a metastasizing paraganglioma: preparation and preclinical studies.
    Freiberg B; Puhlmann CM; Anderer FA
    Anticancer Res; 1995; 15(6B):2489-93. PubMed ID: 8669812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro binding to granulocytes of two anti-NCA 95 monoclonal antibodies: Mab1 (ORIS) and Mabgc (Mallinckrodt).
    Collet B; Moisan A; Maros S; Toujas L; Herry JY
    Prog Clin Biol Res; 1990; 355():293-8. PubMed ID: 2281109
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro and in vivo functional evaluation of anti-human bladder tumor human-mouse chimeric antibody ch-BDI].
    Bai Y; Yu LZ; Lü YQ; Ai JK; Zhang CL; Ding Y; Wang Y
    Zhonghua Wai Ke Za Zhi; 2003 Feb; 41(2):96-8. PubMed ID: 12783667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody homodimers: enhanced antitumor activity in nude mice.
    Wolff EA; Schreiber GJ; Cosand WL; Raff HV
    Cancer Res; 1993 Jun; 53(11):2560-5. PubMed ID: 8495420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor size: effect on monoclonal antibody uptake in tumor models.
    Hagan PL; Halpern SE; Dillman RO; Shawler DL; Johnson DE; Chen A; Krishnan L; Frincke J; Bartholomew RM; David GS
    J Nucl Med; 1986 Mar; 27(3):422-7. PubMed ID: 3486953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts.
    Brekken C; Hjelstuen MH; Bruland ØS; de Lange Davies C
    Anticancer Res; 2000; 20(5B):3513-9. PubMed ID: 11131655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitumor effect of nanospheres coupled with the anti-human liver cancer monoclonal antibody HAb18].
    Kan HP; Liu ZJ; Tan YF; Lin YX; Li CF; Zhou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1503-5. PubMed ID: 18753092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
    Masui H; Moroyama T; Mendelsohn J
    Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs.
    Wittel UA; Jain M; Goel A; Chauhan SC; Colcher D; Batra SK
    Nucl Med Biol; 2005 Feb; 32(2):157-64. PubMed ID: 15721761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional delivery of monoclonal antitumor antibodies: detection and possible treatment of lymph node metastases.
    Weinstein JN; Holton OD; Black CD; Keenan AM; Covell DG; Spaulding GF; Barbet J; Steller MA; Sieber SM; Talley MJ
    Prog Clin Biol Res; 1986; 212():169-81. PubMed ID: 3714728
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypothesis: macrophages as effector cells for human tumor destruction mediated by monoclonal antibody.
    Steplewski Z; Herlyn D; Maul G; Koprowski H
    Hybridoma; 1983; 2(1):1-5. PubMed ID: 6678794
    [No Abstract]   [Full Text] [Related]  

  • 18. Mouse and human monoclonal antibodies against gastric cancer. Preparation and clinical application.
    Fan DM; Zhang XY; Chen XT; Mu ZX; Hu JL; Qiao TD; Chen BJ
    Chin Med J (Engl); 1988 Jul; 101(7):488-9. PubMed ID: 3147845
    [No Abstract]   [Full Text] [Related]  

  • 19. Radioimmunodiagnosis of ovarian cancer using 123I-labelled, tumor-associated monoclonal antibodies.
    Epenetos AA; Shepherd J; Britton KE; Hawkins L; Nimmon CC; Taylor-Papadimitriou J; Durbin H; Malpas JS; Mather S; Granowska M
    Cancer Detect Prev; 1984; 7(1):45-9. PubMed ID: 6367983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of organ distribution and elimination rates of 125-I-iodophenylalanine and 75-Se-selenomethionine in mice and dogs.
    Meinhold M; Hollihn U; Schwartz-Porsche D
    J Nucl Biol Med; 1975; 19(1):12-21. PubMed ID: 1141993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.